Stay updated on mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial.

Sign up to get notified when there's something new on the mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial. page.
Latest website image capture
Clouds background image

Latest updates to the mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial. page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision metadata updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T18:06:04.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Added Melanoma and related topics, including MedlinePlus Genetics, to the page's related resources. Updated the revision note to Revision: v3.4.3 and removed the previous Revision: v3.4.2.
    Difference
    0.2%
    Check dated 2026-03-11T16:46:43.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    - Removal of key topic keywords 'Melanoma' and the related topics section 'MedlinePlus Genetics' from the page content. This affects how the study's scope is communicated and indexed.
    Difference
    0.1%
    Check dated 2026-03-04T12:24:38.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    - Added Related Topics: Melanoma and MedlinePlus Genetics to the study page to provide supplementary background resources. This does not modify core study content.
    Difference
    0.1%
    Check dated 2026-02-25T08:44:56.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The government funding operating-status notice and the Revision: v3.4.1 entry were removed.
    Difference
    0.4%
    Check dated 2026-02-11T02:49:27.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    A site-wide operating status notice and a revision update were added, and a few study-related topics/keywords were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T00:48:49.000Z thumbnail image

Stay in the know with updates to mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial.

Enter your email address, and we'll notify you when there's something new on the mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial. page.